Abstract:For clinical applications, a sensor of cancer cells should exhibit high sensitivity, have a small and robust sensing structure, and exhibit good anti-interference. This paper presents a novel biosensor for the recognition and concentration detection of biotin receptor (BR)-overexpressed cancer cells. This biosensor uses a hydrogel composed of biotin-quantum dots (BQDs) grafted onto oxidized sodium alginate with carboxymethyl chitosan (BQDs-g-OSA/CMCS) and a double optical fiber ball (DOFB) sensing structure. The developed BQDs-g-QSA/CMCS hydrogel exhibited specific recognition capabilities for cancer cells and an excellent fluorescence stability. Meanwhile, the proposed DOFB structure was small and presented a strong robustness and integrated fluorescence excitation and reception, which are favorable for in vivo sensing. In addition, in-depth study of the sensing performance of the sensor was conducted by utilizing streptavidin (SV) protein and BR-overexpressed cancer cells (leukemia cells, K562). The experimental results revealed a linear relationship between the photoluminescence intensity of the sensor and concentrations of SV and K562, with minimum detection concentrations of 1.62 nM and 1.0 × 10 3 cells/mL, respectively. In addition, the specificity of the sensor was confirmed through investigation of the its response to another BR-overexpressed cancer cell type (lung cancer cells, A549) and normal cells (human gastric mucosal epithelial, GES-1). The sensor exhibited similar responses to A549 as to K562 cells but not to GES-1 cells, which indicates its specificity toward cancer cells with BR overexpression. In summary, the proposed sensor offers important potential for applications in cancer diagnosis and treatment.

Detection of the cancer marker CD146 expression in melanoma cells with semiconductor quantum dot label.

Breast Cancer Cell Imaging Using Semiconductor Quantum Dots

Application of Semiconductor Quantum Dots for Breast Cancer Cell Sensing

Single-Domain Antibody Functionalized CdSe/ZnS Quantum Dots for Cellular Imaging of Cancer Cells

Preparation of Bioconjugates of CdTe Nanocrystals for Cancer Marker Detection

Arginine-Glycine-Aspartic Acid-Conjugated Dendrimer-Modified Quantum Dots For Targeting And Imaging Melanoma

Enhanced Imaging of Glycan Expressing Cancer Cells Using Poly(glycidyl Methacrylate)-Grafted Silica Nanospheres Labeled with Quantum Dots.

Au:Cdhgte Quantum Dots for in Vivo Tumor-Targeted Multispectral Fluorescence Imaging

Immunofluorescent Labeling of Cancer Cells with Quantum Dots Synthesized in Aqueous Solution

Molecular Profiling of Single Cancer Cells and Clinical Tissue Specimens with Semiconductor Quantum Dots.

Direct And Indirect Immunolabelling Of Hela Cells With Quantum Dots

Analysis of Cancer Marker in Tissues with Hadamard Transform Fluorescence Spectral Microscopic Imaging.

A recognition-before-labeling strategy for sensitive detection of lung cancer cells with a quantum dot-aptamer complex.

Specific, sensitive, and reliable sensing of cancer cells based on quantum dot/hydrogel-coated double optical fiber ball

Characterization and Cancer Cell Targeted Imaging Properties of Human Antivascular Endothelial Growth Factor Monoclonal Antibody Conjugated Cdte/Zns Quantum Dots

In vivo cancer targeting and imaging with semiconductor quantum dots

Use of Quantum Dots in the Development of Assays for Cancer Biomarkers.

CD146‐targeted Nuclear Medicine Imaging in Cancer: State of the Art

Quantum Dots Based Molecular Beacons for in Vitro and in Vivo Detection of MMP-2 on Tumor.

ImmunoPET of the Differential Expression of CD146 in Breast Cancer.

Immunofluorescent Labeling of Human HepG2 Cells with CdTe Quantum Dot Probe Conjugated with Anti-pan CK MAb